GLP1/E, at very low doses, is sufficient to ameliorate PCOS-associated metabolic alterations Since GLP1/E was superior to any other compound in terms of improvement of metabolic traits, we next assessed the metabolic efficacy of very low doses of this multi-agonist in our metabolically dysregulated PCOS model
Treating your fatty liver isnt just about saving your liverit is about protecting your entire body
In addition to New Hampshire, California and South Carolina plan to end coverage of the drugs in January
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Provides firmer and smoother skin also reduces fine lines
Interrogation of real-world data sets using the Explorys system to assess cancer rates in 300 different healthcare systems in the USA following initiation of GLP-1RA therapy in 64,230 individuals with type 2 diabetes revealed lower rates of prostate, lung and colon cancer, but higher rates of thyroid cancer [164]